16 Feb 2009 11:26
Immediate Release: Monday 16th February 2009
Plethora Solutions Holdings plc
("Plethora" or "the Company")
Result of General Meeting
Plethora Solutions Holdings plc (AIM: PLE) announces that at the General Meeting held earlier today, all resolutions were duly passed.
Accordingly the Company will proceed with the placing of £1m on convertible loan notes as announced in January 2009.
-Ends-
For further information contact:
| Plethora Solutions Steven Powell | Tel : 020 3077 5406 |
| FinnCap Geoff Nash | Tel: 020 7600 1658 |
| Hansard Group Adam Reynolds/John Bick | Tel: 020 7245 1100 |
About Plethora:
Plethora is focused on the development and marketing of products for the treatment of urological disorders. The Company has products in clinical development for the treatment of overactive bladder, stress urinary incontinence, interstitial cystitis, gynaecological pain, erectile dysfunction and premature ejaculation. Plethora has a US subsidiary, Timm Medical Technologies Inc, which markets products for the treatment of erectile dysfunction (ED) to urology clinics through a national US specialty sales team. The Company is headquartered in the UK and is listed on the London Stock Exchange (AIM:LSE). Further information is available at www.plethorasolutions.co.uk.